>>> US Research Calls I

Research Calls I
  • Upgrades
    • Chord Energy (CHRD) upgraded to Buy from Neutral at BofA Securities, tgt $114
    • Crane (CR) upgraded to Buy from Neutral at UBS, tgt $190
    • Diamondback Energy (FANG) upgraded to Buy from Neutral at BofA Securities; tgt $170
    • Upstart (UPST) upgraded to Neutral from Underperform at BofA Securities, tgt $53
  • Downgrades
    • Air Liquide (AIQUY) downgraded to Neutral from Overweight at JPMorgan
    • Avantor (AVTR) downgraded to Neutral from Buy at Goldman, tgt $14
    • Builders FirstSource (BLDR) downgraded to Hold from Buy at Stifel, tgt $125
    • ConocoPhillips (COP) downgraded to Neutral from Buy at BofA Securities; tgt $107
    • Hims & Hers (HIMS) downgraded to Hold from Buy at TD Cowen, tgt $30
    • Icon (ICLR) downgraded to Neutral from Overweight at JPMorgan, tgt $150
    • InMode (INMD) downgraded to Neutral from Buy at BTIG Research
    • Insulet (PODD) downgraded to Peer Perform from Outperform at Wolfe Research
    • Lufax (LU) downgraded to Sell from Hold at Deutsche Bank, tgt $2.40
    • LVMH (LVMUY) downgraded to Neutral from Outperform at BNP Paribas Exane
    • National Grid (NGG) downgraded to Neutral from Buy at UBS
    • Volaris (VLRS) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $4.40
    • Volaris (VLRS) downgraded to Equal Weight from Overweight at Barclays, tgt $4.50
  • Others
    • Apellis (APLS) initiated with an Overweight at Cantor Fitzgerald, tgt $44
    • Astria Therapeutics (ATXS) initiated with an Overweight at Cantor Fitzgerald, tgt $47
    • BioCryst (BCRX) initiated with an Overweight at Cantor Fitzgerald, tgt $20
    • InflaRx (IFRX) initiated with an Overweight at Cantor Fitzgerald, tgt $10
    • Kinetik Holdings (KNTK) initiated with a Neutral at UBS, tgt $49
    • Korro Bio (KRRO) initiated with an Overweight at Cantor Fitzgerald, tgt $74
    • Matson (MATX) initiated with a Buy at Jefferies, tgt $125
    • Pharvaris (PHVS) initiated with an Overweight at Cantor Fitzgerald, tgt $28
    • ProQR Therapeutics (PRQR) assumed with an Overweight at Cantor Fitzgerald, tgt $8
    • ProQR Therapeutics (PRQR) initiated with an Outperform at Evercore ISI, tgt $5
    • Qualcomm (QCOM) resumed with an Overweight at JP Morgan; tgt lowered to $185
    • Strategy (MSTR) initiated with a Buy at H.C. Wainwright, tgt $480
    • Viking Therapeutics (VKTX) initiated with an Overweight at Cantor Fitzgerald, tgt $104
    • Wave Life Sciences (WVE) initiated with an Overweight at Cantor Fitzgerald, tgt $10